The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time as ...
Copyright: © 2026 World Health Organization; licensee Elsevier Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results